Explaining key stakeholders' preferences for potential policies governing psychiatric electroceutical intervention
Aaron M McCright1, Eric D Achtyes2, Robyn Bluhm3
1Department of Sociology, Michigan State University, East Lansing, MI, USA. mccright@msu.edu.
Npj Mental Health Research
|November 7, 2024
Summary
Stakeholder views on psychiatric electroceutical interventions (PEIs) vary significantly, particularly between psychiatrists and the public. Policymakers must consider these differences when creating laws for PEI use in mental health treatment.
Area of Science:
- Neuroscience and Psychiatry
- Health Policy and Law
Background:
- Legislative proposals for psychiatric electroceutical interventions (PEIs) are increasing.
- PEIs utilize electrical or magnetic stimulation for mental disorder treatment.
Purpose of the Study:
- To analyze how stakeholder views on PEIs align with policy preferences.
- To identify differences in policy preferences among psychiatrists, patients, caregivers, and the public.
Main Methods:
- Survey data from national samples of psychiatrists, patients, caregivers, and the general public.
- Analysis of preferences for policies governing four PEIs for major depressive disorder.
Main Results:
- Non-clinician groups (patients, caregivers, public) showed similar policy preferences.
- Psychiatrists' preferences significantly differed from non-clinician groups.
- The greatest policy divide was observed regarding electroconvulsive therapy (ECT).
- Differences were more pronounced for access-reducing than access-expanding policies.
Conclusions:
- Significant divergence exists between clinician and non-clinician preferences for PEI regulation.
- Policymakers need to account for stakeholder-specific views on PEI availability.
- Legislation should consider variations across PEI modalities and stakeholder groups.
Related Concept Videos
01:30Psychosurgery
46
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
46
01:30Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
01:26Psychosis: Goals of Pharmacotherapy
104
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
104
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:27Ethical Issues
856
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Concerns in Healthcare:
856
01:03Drug Control Governance: Regulatory Bodies and Their Impact
144
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
144